1. A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers. Issue 6 (2nd June 2020) Authors: Fujita, Ryo; Blot, Vincent; Wong, Eley; Stewart, Christine; Lieuw, Vincent; Richardson, Robyn; Banah, Ammar; Villicana, Jose; Timmer, Anjuli; Coronella, Julia; Newman, Roland; Gymnopoulos, Marco Journal: Cancer biology & therapy Issue: Volume 21:Issue 6(2020) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗